Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Pool Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112521352A details a novel route for (R)-4-propyl-dihydrofuran-2-one. This method offers cost reduction in API manufacturing and scalable production.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN115850240B reveals a two-step route for Olutasidenib. This method ensures high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN112920053B details a mild, high-yield route for chiral amines used in asthma and oncology drugs, offering significant supply chain stability.
Patent CN114315866B enables eco-friendly levamisole hydrochloride production via L-mandelic acid route eliminating chiral catalysts and reducing waste for enhanced supply chain resilience.